How can I determine local antimicrobial resistance patterns for urinary pathogens in a patient with a percutaneous endoscopic gastrostomy (PEG) tube and a complicated urinary infection?

How to Determine Local Antimicrobial Resistance Patterns

Contact your hospital's clinical microbiology laboratory or infection control department to obtain institution-specific antibiograms, which are cumulative antimicrobial susceptibility reports typically published annually that show resistance rates for common pathogens in your facility. 1

Primary Sources for Local Resistance Data

Hospital-Based Resources

Your most actionable source is your institution's antibiogram, which should be:

• Updated annually by your microbiology laboratory
• Stratified by infection site (urine, blood, wound)
• Separated by patient location (ICU vs. general ward vs. outpatient)
• Available through your infection control or antimicrobial stewardship program

The 2024 EAU guidelines explicitly state that empiric antibiotic selection for complicated UTIs "should be based on local resistance patterns and optimised" 1. This is not optional guidance—it's fundamental to appropriate prescribing.

Key Contacts in Your Institution

• Clinical microbiology laboratory director: Can provide detailed susceptibility data
• Antimicrobial stewardship team: Maintains updated resistance trends and prescribing guidance
• Infection control department: Tracks multidrug-resistant organisms and healthcare-associated infections
• Pharmacy department: Often maintains formulary guidelines based on local resistance

Understanding Antibiogram Data

Critical Thresholds to Know

For fluoroquinolones specifically, the EAU guidelines state resistance should be <10% to justify empiric use 1. If your local fluoroquinolone resistance exceeds this threshold in E. coli, you should not use these agents empirically for uncomplicated pyelonephritis.

Stratification That Matters

Request antibiograms stratified by:

• Community-acquired vs. healthcare-associated infections: Resistance rates differ dramatically 2
• Specimen type: Urine isolates have different patterns than blood cultures
• Patient risk factors: Prior antibiotic exposure, recent hospitalization, presence of foreign bodies (like your patient's PEG tube) 1

Special Considerations for Your Patient

Your patient with a PEG tube and complicated UTI represents a high-risk scenario. The presence of a foreign body (PEG tube) classifies this as a complicated UTI 1, and PEG tubes themselves can harbor drug-resistant bacteria 3. Research shows that 19.6% of PEG tubes are contaminated with drug-resistant bacteria 3.

Risk Factors Increasing Resistance Likelihood

• Foreign body present (PEG tube)
• Healthcare-associated infection risk
• Potential for multidrug-resistant organisms 1
• Broader microbial spectrum than uncomplicated UTI (E. coli, Proteus, Klebsiella, Pseudomonas, Serratia, Enterococcus) 1

When Local Data Is Unavailable

If your institution lacks comprehensive antibiograms:

1. Request creation of one: This is a standard quality improvement measure
2. Use regional surveillance data: State or regional health departments often publish resistance trends
3. Consult national surveillance programs: CDC's Antibiotic Resistance Patient Safety Atlas or similar resources
4. Default to broader-spectrum coverage: In the absence of local data, err toward broader empiric coverage for complicated infections, then de-escalate based on culture results 4, 5

Practical Implementation

For Empiric Therapy Selection

• Always obtain urine culture before starting antibiotics 1
• Choose empiric therapy based on local resistance patterns
• Plan for antimicrobial de-escalation once susceptibilities return 4, 5
• For complicated UTIs with multidrug-resistant risk, consider carbapenems or novel agents only if early culture results indicate resistance 1

Common Pitfall to Avoid

Do not rely on outdated guidelines or national recommendations alone 6. A study of PEG placement practices found that only 20.2% of sites based decisions on national recommendations, and many used outdated evidence 6. Your local resistance patterns may differ substantially from national averages 7, 8.

Monitoring Resistance Trends

Request quarterly or semi-annual updates from your microbiology laboratory, particularly for:

• Extended-spectrum β-lactamase (ESBL) rates in Enterobacteriaceae
• Carbapenem resistance rates
• Fluoroquinolone resistance in E. coli
• Multidrug-resistant Pseudomonas rates

Research demonstrates substantial variation in resistance patterns even within the same country 7, 8, making local data essential rather than optional for optimal patient outcomes.